@article{e1d2fb825ab945c6bb0c3f7ea2ab350f,
title = "Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation",
abstract = "This study investigated whether switching from the twice-daily (Prograf; TAC) to the once-daily formulation of tacrolimus with extended release (Advagraf; XL) affected quality of life, anxiety, and transplant benefit perception after allogeneic kidney transplantation.",
keywords = "Adult, Aged, Analysis of Variance, Anxiety, Delayed-Action Preparations, Drug Administration Schedule, Drug Monitoring, Female, Graft Rejection, Health Knowledge, Attitudes, Practice, Humans, Immunosuppressive Agents, Italy, Kidney Transplantation, Male, Middle Aged, Perception, Psychiatric Status Rating Scales, Quality of Life, Questionnaires, Tacrolimus, Time Factors, Treatment Outcome, Truth Disclosure, Adult, Aged, Analysis of Variance, Anxiety, Delayed-Action Preparations, Drug Administration Schedule, Drug Monitoring, Female, Graft Rejection, Health Knowledge, Attitudes, Practice, Humans, Immunosuppressive Agents, Italy, Kidney Transplantation, Male, Middle Aged, Perception, Psychiatric Status Rating Scales, Quality of Life, Questionnaires, Tacrolimus, Time Factors, Treatment Outcome, Truth Disclosure",
author = "R. Calia and Rosaria Calia and Carlo Lai and Paola Aceto and M. Luciani and Massimiliano Luciani and Jacopo Romagnoli and S. Lai and Antonio Gargiulo and Franco Citterio",
year = "2011",
doi = "10.1016/j.transproceed.2011.03.048",
language = "English",
volume = "43",
pages = "1020--1023",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier Inc.",
}